SYRE
Spyre Therapeutics Inc.
$24.46
+$0.20(+0.82%)
52
Overall
60
Value
66
Tech
31
Quality
Market Cap
$959.77M
Volume
683.32K
52W Range
$10.91 - $40.26
Target Price
$52.91
EPS Estimates Overview
| Current Quarter | $-0.68 | Next Quarter | $-0.66 |
| Current Year | $-2.6 | Next Year | $-3.06 |
| QoQ Growth | +2.9% | YoY Growth | -17.7% |
| 3Y EPS CAGR | +0.0% | Target Price | $52.91 |
| Consensus | Buy | Upside | +116.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $24.46 | +0.8% | 683.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |